Physicians play a critical role in the uptake of generic medicines in the Philippines, being in control of drug prescriptions while also enjoying high trust from patient-consumers. However, their negative perceptions on generic medicines have arisen as an issue that could influence their prescribing practices for generic drugs. To gain further insights into the problem, a cross-sectional survey was conducted among practicing physicians in Baguio City, assessing their state of knowledge, perceptions, attitudes and practices relative to generic medicines and the Generics Act of 1988. Results revealed knowledge gaps on the therapeutic capability of generic medicines, and the generic law’s provision on generic dispensing; persistent low regard for generic drugs and their quality assurance standards; continuing opposition to the specific provision on generic dispensing; and, finally, low or even non-compliance to generic prescribing. Aside from recommendations on continuing information and education of physicians together with a stricter and consistent monitoring of their prescription practices, the study calls for investigation into the influence of drug companies on the persistence of negative perceptions among physicians.
Keywords: medicines in the Philippines, challenges to generics, generic drugs, generic prescribing, generic dispensing, RA 6675[1] Alkhaled, L., Kahale, L., Nass, H., Brax, H., Fadlallah, R., Badr, K., Akl, E. A. (2014). Legislative, educational, policy and other interventions targeting physicians` interaction with pharmaceutical companies: a systematic review. BMJ Open, 4(7):e004880. https://bmjopen.bmj.com/content/bmjopen/4/7/e004880.full.pdf
[2] Berger, K. (2018, May 17). The FDA, generics and differentiating authorized from branded types. Pharmacy Times. www.pharmacytimes.com/contributor/karen-berger/2018/05/the-fda-generics-and-differentiating-authorized-from-branded-types
[3] Boumil, M. M., Cutrell, E. S., Lowney, K.E., & Berman, H. A. 2012. Pharmaceutical speakers’ bureaus, academic freedom, and the management of promotional speaking at academic medical centers. The Journal of Law, Medicine and Ethics, 40, 311–325.
[4] Chren, M. M., & Landefeld, C. S. (1994). Physicians’ behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary. Journal of the American Medical Association, 271, 684–689.
[5] Chua, G.N., Hassali, M.A., Shafie, A.A., & Awaisu, A. (2010). A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia. Health Policy, 95(2–3), 229–235.
[6] Co, E. E. (1998). Management of Policy Formulation: The Generics Act of 1988. Philippine Journal of Public Administration, 42(3 & 4), 291-320.
[7] Dantes, R. B. (1991). The new Philippine generic drugs act: A physician’s viewpoint. Journal of Clinical Epidemiology, 45(Supp. 20), 29-30.
[8] Food and Drug Authority. (2013). List of Products Requiring Bioequivalence (BE) Studies as part of the Application Marketing Authorization in Addition to Rifampicin and the 11 Products Listed in Bureau Circular No. 2006-008. FDA Circular No. 2013-014. https://ww2.fda.gov.ph/issuances//79848-fda-circular-no-2013-014
[9] Food and Drug Authority. (2016). Revised Guidelines on the Submission of Equivalence Evidence for Registration of Pharmaceutical Products. FDA Circular No. 2016-019. https://ww2.fda.gov.ph/attachments/article/374774/FDA%20Circular%20No.%202016-019.pdf
[10] Fischer, M. A., Keough, M. E., Baril, J. L., Saccoccio, L., Mazor, K. M., Ladd, E., Von Worley, A., & Gurwitz, J. H. (2009). Prescribers and pharmaceutical representatives: why are we still meeting? Journal of General Internal Medicine, 24(7), 795-801.
[11] Grande, D. (2010). Limiting the Influence of Pharmaceutical Industry Gifts on Physicians: Self-Regulation or Government Intervention. Journal of General Internal Medicine, 25(1), 79–83.
[12] Generics and Biosimilars Initiative. (2012). WHO definitions of generics. GaBi Online. https://gabionline.net/Generics/General/WHO-definitions-of-generics
[13] Hartigan-Go, K. (2001). The pharmaceutical situation in the Philippines. Australian Health Review, 24(2), 25–31.
[14] Hassali, M.A., Kong, D.C.M., & Stewart, K. (2006). Generic medicines: perceptions of general practitioners in Melbourne, Australia. Journal of Generic Medicine, 3, 214–25.
[15] Jamshed, S.Q., Hassali, M.A., Ibrahim, M.I., & Babar, Z.U. (2011). Knowledge attitude and perception of dispensing doctors regarding generic medicines in Karachi, Pakistan: a qualitative study. Journal of Pakistan Medical Association, 61(1), 80–83.
[16] Kowalczyk, L. (2007, December 24). UMass policy limits doctor, drug maker ties: Conflict of interest rules among strictest in country. The Boston Globe. http://archive.boston.com/business/healthcare/articles/2007/12/24/umass_policy_limits_doctor_drug_maker_ties/
[17] Ku, G. M. (2017). Factors affecting use of generics drugs in the Philippines. Conference: European Congress on Tropical Medicine and International Health. https://doi.org/10.13140/RG.2.2.14427.46882
[18] Latwal, B. & Chandra, A. (2020). Authorized generics vs. branded generics: A perspective. Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector. https://doi.org/10.1177/1741134320947773
[19] Nguyen, T., Hassali. M., & McLachlan, A. (2013). Generics medicines policies in the Asia Pacific region: ways forward. WHO South East Asia Journal of Public Health, 2, 72-74.
[20] Nissanholtz-Gannot, R., & Yankellevich, A. (2017). Regulating the relationship between physicians and pharmaceutical companies: a qualitative and descriptive analysis of the impact of Israeli legislation. Israeli Journal of Health Policy Research, 6(1), 45.
[21] Pabico, A. (2006a, September 27). It’s not easy being generic. Philippine Center for Investigative Journalism. https://old.pcij.org/stories/its-not-easy-being-generic/
[22] Pabico, A. (2006b, September 27). New Rx needed for generics movement. Philippine Center for Investigative Journalism. https://old.pcij.org/stories/new-rx-needed-for-generics-movement/
[23] Republic Act no. 6675. (1988). An act to promote, require and ensure the production of an adequate supply, distribution, use and acceptance of drugs and medicines identified by their generic names. https://www.officialgazette.gov.ph/1988/09/13/republic-act-no-6675/
[24] Sah, S., & Fugh-Berman, A. (2013). Physicians under the influence: social psychology and industry marketing strategies. The Journal of Law, Medicine and Ethics, 41, 665–672.
[25] Sharrad, A. K., Hassali, M.A., & Shafie, A.A. (2009). Generic medicines: Perception of Physicians in Basrah, Iraq. Australasian Medical Journal, 1(8), 58-64.
[26] Tan, M. (2013, October 1). Generics at 25. Philippine Daily Inquirer. https://opinion.inquirer.net/62437/generics-at-25
[27] Toverud, E. L., Hartmann, K., & Hakonsen, H. A. (2015). Systematic Review of Physicians’ and Pharmacists’ Perspectives on Generic Drug Use: What are the Global Challenges? Applied Health Economics and Health Policy, 13 (Suppl 1), S35–S45.
[28] U.S. Food and Drug Administration. [n.d.] A Primer on Generic Drugs and Bioequivalence: an overview of the generic drug approval process. https://www.fda.gov/media/89135/download
[29] World Health Organization. (2016). Generic medicines. WHO Drug Information, 30(3). https://www.who.int/medicines/publications/druginformation/WHO_DI_30-3_GenericMedicines.pdf?ua=1
[30] Wong, J. Q., Baclay, J. R., Duque, R. G., Roque, P. M., Serrano, G. K., Tumlos, J. O., Ronsing, A. A., & Cochon, K. (2013). Prevalence of Philippine Prescribing, Dispensing, and Use Behavior in Relation to Generic drugs. Philippine Journal of Development, 40(1&2), 125-159.
[31] Wong, J. Q., Baclay, J. R., Duque, R. G., Roque, P. M., Serrano, G. K., Tumlos, J. O., Ronsing, A. A., & Cochon, K. (2016, February). How effective has the Generics Act been? Philippine Institute of Development Studies. https://think-asia.org/handle/11540/6426
[32] Yadao-Guno, C. (1991). The Generics Act of 1988: Policy Formulation and Implementation Under Pressure. Philippine Journal of Public Administration, 35(4), 369-390.
[33] Zaverbhai, K. D., Dilipkumar, K. J., Kalpan, D. C., Kiran, D. M. (2017). Knowledge, Attitude and Practice of Resident Doctors for use of Generic Medicines at a Tertiary care Hospital. Journal of Young Pharmacists, 9(2), 263-266.